Skip to main content
Toggle navigation
Search
Home
Back
Like
Post
Li Xie
Takeda Pharmaceutical Company Ltd., China (People's Republic)
Poster(s):
P0914 - Clinical Effectiveness and Safety of Vedolizumab in Patients With Crohn’s Disease in China: Results From a Real World Study
Sunday, October 27, 2024
3:30 PM – 7:00 PM
ET